$71.39+0.37 (+0.52%)
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
The Cooper Companies, Inc. in the Healthcare sector is trading at $71.39 with a market capitalization of $13.2B. Wall Street consensus targets $80.57 (14 analysts), implying a +12.9% move over the next 12 months. The stock is currently 21% below its 52-week high of $89.83, remaining 1.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.02B↓ | $1.07B↑ | $1.06B↑ | $1.00B↑ | $964.70M |
| Gross Profit | $695.20M↑ | $650.80M↓ | $692.00M↑ | $679.10M↑ | $660.20M |
| Operating Income | $212.80M↑ | $140.40M↓ | $175.70M↓ | $184.80M↑ | $182.00M |
| Net Income | $130.80M↑ | $84.60M↓ | $98.30M↑ | $87.70M↓ | $104.30M |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifo...
Cooper Companies Inc (NASDAQ:COO) is one of the best stocks to buy according to Billionaire Barry Rosenstein. This stock is backed by 49 hedge funds, and analysts see the stock rising at least 17% from its current price in the next 12 months. On June 12, Stifel reiterated a Buy rating on Cooper Companies Inc […]
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Cooper Companies has lagged behind the healthcare sector over the past year, and analysts remain moderately bullish about its prospects.
Investors may be wondering whether Cooper Companies is priced attractively today, or if the stock still looks expensive at around US$67.88 per share. The price has inched up about 0.8% over the last week and 13.9% over the last month, even though the year to date return is a decline of 16.3% and the 1 year return is a decline of 2.6%. These mixed returns sit against a longer backdrop where the stock is down 26.1% over 3 years and down 29.3% over 5 years. This may have reset expectations for...